Stock data
Tempest Therapeutics, Inc. (TPST)
Tempest Therapeutics, Inc. (TPST) reported net income of -US$26.26M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$26.57M | -US$26.26M | — |
| 2024 | — | — | -US$42.03M | -US$41.84M | — |
| 2023 | — | — | -US$29.16M | -US$29.49M | — |
| 2022 | — | — | -US$34.64M | -US$35.71M | — |
| 2021 | — | — | -US$26.99M | -US$28.30M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$5.24M | — |
| 2026-03-31 | — | -US$27.70M | — |
| 2025-12-31 | — | -US$4.02M | — |
| 2025-09-30 | — | -US$3.51M | — |
| 2025-06-30 | — | -US$7.87M | — |
| 2025-03-31 | — | -US$10.86M | — |
| 2024-12-31 | — | -US$13.81M | — |
| 2024-09-30 | — | -US$10.56M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.